Susquehanna International Group
WX

Susquehanna International Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Susquehanna International Group’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-209,600
Closed -$9.06M – 10502
2015
Q3 		$9.06M Buy
209,600
+25,600
+14% +$1.08M ﹤0.01% 1942
2015
Q2 		$7.78M Buy
184,000
+174,900
+1,922% +$7.38M ﹤0.01% 2298
2015
Q1 		$353K Buy
+9,100
New +$350K ﹤0.01% 7695
2014
Q4 		– Sell
-11,000
Closed -$385K – 10489
2014
Q3 		$385K Sell
11,000
-7,600
-41% -$261K ﹤0.01% 7648
2014
Q2 		$611K Buy
18,600
+3,700
+25% +$127K ﹤0.01% 7094
2014
Q1 		$549K Sell
14,900
-4,300
-22% -$158K ﹤0.01% 6578
2013
Q4 		$737K Buy
+19,200
New +$606K ﹤0.01% 6055

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Susquehanna International Group's WX Position: Q4 2015 in Review

Susquehanna International Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 238,914 shares — an estimated $10.3M sold.

Susquehanna International Group first reported a position in WX in Q4 2013 and held it in 6 quarters. The position peaked at $10.3M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Susquehanna International Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Susquehanna International Group sold 238,914 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $10.3M.
  • Susquehanna International Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 6 quarters.
  • Susquehanna International Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $10.3M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Susquehanna International Group's 13F filing for Q4 2015, filed 16 Feb 2016.